The Belt and Road: Cooperation, Harmony and Win-Win
products

Nutraceutical

  • Pramlintide CAS:151126-32-8

    Pramlintide CAS:151126-32-8

    Pramlintide is a synthetic form of amylin, a hormone secreted by the pancreas along with insulin to help regulate blood sugar levels. It is used in combination with insulin therapy to improve blood sugar control in patients with type 1 or type 2 diabetes.

  • Lixisenatide CAS:320367-13-3

    Lixisenatide CAS:320367-13-3

    Lixisenatide is a glucagon-like peptide-1 (GLP-1) receptor agonist used to manage blood sugar levels in patients with type 2 diabetes. It works by stimulating insulin secretion and inhibiting glucagon release, leading to improved glucose control. Lixisenatide is administered via subcutaneous injection once daily and is often prescribed alongside diet and exercise to achieve better glycemic management.

  • Octreotide CAS:79517-01-4

    Octreotide CAS:79517-01-4

    Octreotide is a somatostatin analogue that inhibits the secretion of multiple hormones by mimicking the effects of natural somatostatin for the treatment of neuroendocrine tumors and related endocrine disorders.

  • Liraglutide CAS:204656-20-2

    Liraglutide CAS:204656-20-2

    Liraglutide is a GLP-1 receptor agonist used to treat type 2 diabetes and obesity. It mimics the action of GLP-1 by promoting insulin secretion and inhibiting the release of glucagon, helping to lower blood sugar levels and weight.

  • Teduglutide CAS:197922-42-2

    Teduglutide CAS:197922-42-2

    Teduglutide is a drug used to treat short bowel syndrome (SBS), a rare condition that can occur after surgical removal of a portion of the small intestine. This drug is a synthetic form of a naturally occurring hormone called glucagon-like peptide-2 (GLP-2), which helps to improve intestinal absorption and reduce the need for parenteral nutrition in patients with SBS.

  • Pasireotide CAS:396091-73-9

    Pasireotide CAS:396091-73-9

    Pasireotide is a multi-receptor targeted drug used to treat specific types of endocrine disorders and related diseases by inhibiting the activity of multiple growth hormone and insulin-like growth factor receptors.

  • Mifamurtide CAS:83461-56-7

    Mifamurtide CAS:83461-56-7

    Mifamurtide is an immunomodulator that acts as a lipopolysaccharide drug to fight tumors by mimicking and enhancing the host’s immune response.

  • Albiglutide CAS:82500-75-8

    Albiglutide CAS:82500-75-8

    Albiglutide is a GLP-1 receptor agonist used to treat type 2 diabetes. It mimics the action of GLP-1 to promote insulin secretion and inhibit glucagon release, helping to control blood sugar levels.

  • Somatostatin CAS:51110-01-1

    Somatostatin CAS:51110-01-1

    Somatostatin is a multifunctional hormone that regulates hormone levels and neurotransmission in the body by inhibiting the release of multiple endocrine and neurotransmitters.

  • Degarelix CAS:214766-78-6

    Degarelix CAS:214766-78-6

    Degarelix is a hormone modulator primarily used to treat prostate cancer and reduces androgen levels in men by inhibiting the release of pituitary hormones.

  • Kisspeptin-10,human CAS:374675-21-5

    Kisspeptin-10,human CAS:374675-21-5

    Kisspeptin-10, human, is a neuropeptide that is part of the Kisspeptin family and regulates physiological processes such as sex hormone secretion and reproductive function by activating Kisspeptin receptors.

  • Cilengitide CAS:188968-51-6

    Cilengitide CAS:188968-51-6

    Cilengitide is an integrin inhibitor that blocks angiogenesis and metastasis and proliferation of tumor cells by inhibiting the activity of integrin receptors.